Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Li, Z.; Kovshova, T.; Malinovskaya, J.; Knoll, J.; Shanehsazzadeh, S.; Osipova, N.; Chernysheva, A.; Melnikov, P.; Gelperina, S.; Wacker, M. G. Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin. International journal of nanomedicine 2024, 19, 2039–2056. doi:10.2147/ijn.s440598
• Cai, J.-y.; Liu, Y.; Zhang, L.; Guo, R.-b.; Liu, Y.; Li, X.-t.; Ma, L.-y.; Kong, L. Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma. Journal of Drug Delivery Science and Technology 2024, 93, 105387. doi:10.1016/j.jddst.2024.105387
• Veselý, O.; Živný, M.; Nigríni, M.; Veselý, J.; Čejka, J. The effect of the active site and substrate structure in preparation of substituted tetrahydropyrans via intramolecular cyclization. Catalysis Today 2024, 429, 114465. doi:10.1016/j.cattod.2023.114465
• Zha, S.; Liu, H.; Li, H.; Li, H.; Wong, K.-L.; All, A. H. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier. ACS nano 2024, 18, 1820–1845. doi:10.1021/acsnano.3c10674
• Zhao, C.; Zhu, X.; Tan, J.; Mei, C.; Cai, X.; Kong, F. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2024, 171, 116113. doi:10.1016/j.biopha.2023.116113
• Rathnam, S. S.; Deepak, T.; Sahoo, B. N.; Meena, T.; Singh, Y.; Joshi, A. Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments. The Journal of pharmacology and experimental therapeutics 2024, 388, 39–53. doi:10.1124/jpet.123.001689
• Kapoor, D.; Sharma, D.; Pathak, Y.; Prajapati, B. G.; Satani, B. Nanoformulations targeting Alzheimer's disease. Alzheimer's Disease and Advanced Drug Delivery Strategies; Elsevier, 2024; pp 265–282. doi:10.1016/b978-0-443-13205-6.00010-8
• Chakraborty, P.; Bhattacharyya, C.; Sahu, R.; Dua, T. K.; Kandimalla, R.; Dewanjee, S. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2024, 91, 105267. doi:10.1016/j.jddst.2023.105267
• Ghosh, B.; Datta, A.; Sarmah, D.; Rana, N.; Chaudhary, A.; Borah, A.; Bhattacharya, P. Nanomaterial-based approach in stroke. Natural Molecules in Neuroprotection and Neurotoxicity; Elsevier, 2024; pp 1935–1958. doi:10.1016/b978-0-443-23763-8.00082-8
• Battaglini, M.; Marino, A.; Montorsi, M.; Carmignani, A.; Ceccarelli, M. C.; Ciofani, G. Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders. Advanced healthcare materials 2023, e2304180. doi:10.1002/adhm.202304180
• Grosso, C.; Silva, A.; Delerue-Matos, C.; Barroso, M. F. Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders. Pharmaceuticals (Basel, Switzerland) 2023, 16, 1721. doi:10.3390/ph16121721
• Yan, T.-H.; Yuan, M.; Nguyen, N.; Chen, J.; Feng, X.; Fan, T.; Harnett, M. C.; Xiao, Z.; Li, Y.; Pellois, J.-P.; Zhou, H.-C.; Wang, Y. Surface-modified gold-coated superparamagnetic iron oxide nanoparticles promoting light-controlled drug release. Advanced Composites and Hybrid Materials 2023, 6. doi:10.1007/s42114-023-00811-4
• Chen, Y.-J.; Paul, A.; Collins, M. G.; Lee, H. Y. The changing landscape of gene editing tool delivery in neurological disorders. Current Opinion in Biomedical Engineering 2023, 28, 100509. doi:10.1016/j.cobme.2023.100509
• Sri Kanaka Durga Vijayalakshmi, G.; Puvvada, N. Recent Advances in Chemically Engineered Nanostructures Impact on Ischemic Stroke Treatment. ACS omega 2023, 8, 45188–45207. doi:10.1021/acsomega.3c06228
• Tashima, T. Carrier-Mediated Delivery of Low-Molecular-Weight N-Containing Drugs across the Blood–Brain Barrier or the Blood–Retinal Barrier Using the Proton-Coupled Organic Cation Antiporter. Future Pharmacology 2023, 3, 742–762. doi:10.3390/futurepharmacol3040046
• Xue, S.; Zhou, X.; Yang, Z.-H.; Si, X.-K.; Sun, X. Stroke-induced damage on the blood-brain barrier. Frontiers in neurology 2023, 14, 1248970. doi:10.3389/fneur.2023.1248970
• Song, Y. H.; De, R.; Lee, K. T. Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview. Advances in colloid and interface science 2023, 320, 103008. doi:10.1016/j.cis.2023.103008
• Suthar, J. K.; Vaidya, A.; Ravindran, S. Size, Surface Properties, and Ion Release of Zinc Oxide Nanoparticles: Effects on Cytotoxicity, Dopaminergic Gene Expression, and Acetylcholinesterase Inhibition in Neuronal PC-12 Cells. Biological trace element research 2023, 202, 2254–2271. doi:10.1007/s12011-023-03832-8
• Mishra, A.; Kumar, R.; Mishra, J.; Dutta, K.; Ahlawat, P.; Kumar, A.; Dhanasekaran, S.; Gupta, A. K.; Sinha, S.; Bishi, D. K.; Gupta, P. K.; Nayak, S. Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system. Journal of Drug Delivery Science and Technology 2023, 86, 104694. doi:10.1016/j.jddst.2023.104694
• Hasan, U.; Chauhan, M.; Basu, S. M.; R, J.; Giri, J. Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs). Drug delivery and translational research 2023, 14, 342–359. doi:10.1007/s13346-023-01401-z

Explore citations to this article at